Dr. Kumanan Wilson
Interim CEO and Chief Scientific Officer of the Bruyère Research Institute and VP, Research and Academic Affairs
Dr. Kumanan Wilson is the Interim CEO and Chief Scientific Officer, Bruyère Research Institute and VP Research & Academic, Bruyère Continuing Care. He had previously served as an innovation advisor for Bruyère.
Dr. Wilson is also a specialist in General Internal Medicine at The Ottawa Hospital and a Full Professor and Faculty of Medicine Clinical Research Chair in Digital Health Innovation at the University of Ottawa. He is the co-founder and Chief Scientific Officer of CANImmunize, a science-based technology company specializing in immunization software.
Dr. Wilson’s research focuses on digital health, health data, immunization, pandemic preparedness and public health policy and innovation. He has received support from multiple organizations including the Canadian Institutes of Health Research (CIHR), the World Health Organization (WHO), The Bill & Melinda Gates Foundation and Canada’s Immunity Task Force.